CompletedPhase IInterventional

Phase I trial: CA47303

This is an early-stage research study, known as CA47303. Researchers are looking for healthy women between 18 and 45 years old to take part. The main goal of this type of study is to learn more about a new investigational treatment, including how safe it is and how it behaves inside the body. Since this is a very early study, the full details about the treatment being tested haven't been made public yet, but they will be available within two and a half years after the study finishes. Taking part helps scientists understand new treatments, but it's important to know it's not designed to treat an illness.

At a glance

Status

Completed

Phase

Phase I

Sponsor

Millicent Puerto Rico LLC

Enrolment target

Start

16 Apr 2025

Estimated completion

18 Apr 2025

Healthy volunteers

What is this study about?

This research study, called CA47303, is what's known as a 'Phase I' trial. Think of it as the very first step in testing a new treatment in people, after it has been thoroughly researched in the lab. The main aim of a Phase I trial is to find out if a new treatment is safe and what dose might be appropriate.

In this specific study, researchers are looking for healthy volunteers, which means people who don't have any known health conditions. This allows them to see how the investigational treatment affects the body without other health problems complicating the results. Because it's such an early stage, full information about what exactly is being tested isn't available to the public yet, but it will be made public within 30 months (two and a half years) after the study is complete.

Contributing to studies like this is very important because it helps scientists learn more about potential new treatments. While the primary goal isn't to help you personally, your participation could contribute to important medical breakthroughs that benefit many people in the future.

Key takeaways

This is an early-stage study to test the safety of a new treatment.
It's looking for healthy women aged 18 to 45.
Participation helps advance medical science.
Full details of the treatment will be made public later.
There is no direct health benefit to you as a participant.

Who may be eligible?

To be able to take part in this particular study, you must be a healthy woman.

You also need to be aged between 18 and 45 years old. This age range is often chosen for early studies to understand how a treatment works in adults who are generally healthy, before testing it in wider groups of people.

Currently, there are no other specific exclusion criteria shared for this study. If you fit these basic requirements, the research team would discuss the full details with you to see if the study is right for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you a woman?
Are you between 18 and 45 years old?
Are you generally healthy?
Are you able to commit to study appointments?

Answer every question to see your result.

What does participation involve?

As the full details of this early-stage study are not yet public, we can't give specific information about what your participation would involve. However, typically in a Phase I study for healthy volunteers, you might expect:

* **Screening Visits:** To check your overall health and make sure you meet all the study requirements. This often includes blood tests, physical exams, and checking your medical history. * **Taking the Investigational Treatment:** You would receive the treatment being studied. This might be given as a pill, injection, or through a drip, and would be done under close medical supervision. * **Study Visits and Assessments:** You would have regular appointments for check-ups, blood tests, and other tests to see how your body is reacting to the treatment and to monitor for any side effects. These visits could be frequent at the start and then less often. * **Duration:** Early phase studies can vary greatly in length, from a few days to several weeks or months, sometimes with follow-up appointments extending beyond the main treatment period. The research team will explain the exact schedule and time commitment required.

All procedures, including any medication you might take, would be clearly explained. You would always have the opportunity to ask questions.

Potential risks and benefits

Taking part in any research study has potential risks and benefits. For healthy volunteers in early-stage studies, a potential benefit is contributing to medical science and helping develop new treatments that could one day help others. However, there is no direct personal health benefit as the study is not designed to treat an existing condition. Potential risks include experiencing side effects from the investigational treatment, which could range from mild to more serious, although studies begin with treatments that have shown promise and safety in lab tests. You also face the inconvenience of study visits. Importantly, you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Celerion GB Ltd
City only
Belfast, United Kingdom

Common questions

What does 'Phase I trial' mean?

It's the first stage of testing a new treatment in people, focusing on safety and how the treatment works in the body, usually with healthy volunteers.

Why are full details about the treatment not available yet?

For very early studies, sometimes full details are held back temporarily, but they will be made public within 30 months after the study has finished.

Will this study help my own health directly?

No, this study is for healthy volunteers to help researchers learn about a new treatment; it's not designed to treat an illness you might have.

Who is funding this research?

The information provided doesn't state who is funding this specific trial. The research team will be able to provide this detail.

Can I leave the study once I've joined?

Yes, you can choose to leave the study at any time, for any reason, without it affecting your future medical care.

How to find out more

Nadine Abdullah

nadine.abdullah@celerion.com +44 2890 554040 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.